Literature DB >> 17765053

Characteristics of hospitalized patients with atrial fibrillation in Taiwan: a nationwide observation.

Cheng-Han Lee1, Ping-Yen Liu, Liang-Miin Tsai, Wei-Chuan Tsai, Ming-Tsung Ho, Jyh-Hong Chen, Li-Jen Lin.   

Abstract

PURPOSE: The aim of the study is to describe the nationwide epidemiological data for hospitalized patients with atrial fibrillation in Taiwan.
METHODS: We collected information on hospitalized patients with discharge-diagnosed atrial fibrillation from 1997 through 2002 from the Taiwan National Health Insurance database. Patients were examined for temporal trends in the frequency of the disease, clinical characteristics, and in-hospital mortality.
RESULTS: Of 162,340 patients (mean age, 73.8 years), 55.3% were men and 38.6% had a primary diagnosis of atrial fibrillation. The mean annual frequency of diagnosed atrial fibrillation was 127 per 100,000 persons. The frequency of atrial fibrillation rose from 91 (1997) to 150 (2002) per 100,000 persons (P <.001); it significantly increased directly with age from 4 per 100,000 in patients <50 years to 1571 per 100,000 in patients > or =80 years. The frequency was significantly higher in men than in women (137 vs 116 per 100,000; P <.001). The average in-hospital mortality rate was 9.3%. In-hospital mortality rate showed a decreasing trend (9.9% vs 7.6%; P = .003). Comorbidities of ischemic heart disease, valvular heart disease, hypertension, ischemic stroke, and congestive heart failure were predictors of higher mortality.
CONCLUSIONS: This Taiwanese study showed a 1.65-fold increase in the frequency of diagnosed atrial fibrillation during the study period. The in-hospital mortality rate, however, declined. The frequency of atrial fibrillation was higher in men and the elderly. We should be more concerned about negative outcomes in hospitalized patients with atrial fibrillation and other coexisting cardiovascular conditions.

Entities:  

Mesh:

Year:  2007        PMID: 17765053     DOI: 10.1016/j.amjmed.2006.10.014

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

1.  Cost-Effectiveness Analysis of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation in Taiwan.

Authors:  Chieh-Yu Liu; Hui-Chun Chen
Journal:  Clin Drug Investig       Date:  2017-03       Impact factor: 2.859

2.  Rationale and design of a prospective, multicenter, cross-sectional study of appropriateness evaluation of the prescription of non-vitamin K antagonist oral anticoagulants for Chinese atrial fibrillation patients (Chi-NOACs-AF trial).

Authors:  Zheng Ding; Chi Zhang; Yi-Yi Qian; Na Wang; Zhi-Chun Gu; Hang Xu; Ying-Li Zheng
Journal:  Ann Transl Med       Date:  2021-04

3.  Diabetes mellitus increased mortality rates more in gender-specific than in nongender-specific cancer patients: a retrospective study of 149,491 patients.

Authors:  Wen-Ko Chiou; Jawl-Shan Hwang; Kuang-Hung Hsu; Jen-Der Lin
Journal:  Exp Diabetes Res       Date:  2012-06-03

4.  Risk of bleeding and stroke with oral anticoagulation and antiplatelet therapy in patients with atrial fibrillation in Taiwan: a nationwide cohort study.

Authors:  Pei-Chun Chen; Gregory Y H Lip; Grace Yeh; Hung-Ju Lin; Kuo-Liong Chien
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

5.  Hormone replacement therapy and risk of atrial fibrillation in Taiwanese menopause women: A nationwide cohort study.

Authors:  Wei-Chung Tsai; Yaw-Bin Haung; Hsuan-Fu Kuo; Wei-Hua Tang; Po-Chao Hsu; Ho-Ming Su; Tsung-Hsien Lin; Chih-Sheng Chu; Shih-Jie Jhuo; Kun-Tai Lee; Sheng-Hsiung Sheu; Chung-Yu Chen; Ming-Tsang Wu; Wen-Ter Lai
Journal:  Sci Rep       Date:  2016-04-07       Impact factor: 4.379

6.  Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry: protocol for a prospective, observational nationwide cohort study.

Authors:  Yutao Guo; Yutang Wang; Xiaoying Li; Zaoliang Shan; Xiangmin Shi; Guorong Xi; Gregory Y H Lip
Journal:  BMJ Open       Date:  2018-05-05       Impact factor: 2.692

7.  Gastroesophageal reflux disease and atrial fibrillation: a nationwide population-based study.

Authors:  Chin-Chou Huang; Wan-Leong Chan; Jiing-Chyuan Luo; Yu-Chun Chen; Tzeng-Ji Chen; Chia-Min Chung; Po-Hsun Huang; Shing-Jong Lin; Jaw-Wen Chen; Hsin-Bang Leu
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

8.  Is Atrial Fibrillation a Risk Factor for Gastroesophageal Reflux Disease Occurrence?

Authors:  Jae Jin Hwang; Dong Ho Lee; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

9.  Hypertension in Middle Eastern Arab and South Asian Patients with Atrial Fibrillation: From a 20-Year Hospital Registry in Qatar (1990-2010).

Authors:  Amar M Salam; Imtiaz Salim; Rasha Kaddoura; Rajvir Singh; Nidal Asaad; Awad Al-Qahtani; Jassim Al Suwaidi; Hajar A AlBinali
Journal:  Heart Views       Date:  2022-02-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.